Group One Trading
FENC icon

Group One Trading’s Fennec Pharmaceuticals FENC Stock Holding History

Group One Trading’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,000
Closed -$22.4K – 7300
2023
Q4 		$22.4K Sell
2,000
-11,000
-85% -$91.1K ﹤0.01% 5657
2023
Q3 		$97.6K Buy
+13,000
New +$106K ﹤0.01% 4478
2023
Q2 		– Sell
-10,500
Closed -$87.4K – 7809
2023
Q1 		$87.4K Sell
10,500
-100
-0.9% -$928 ﹤0.01% 4412
2022
Q4 		$102K Buy
10,600
+5,200
+96% +$46K ﹤0.01% 4427
2022
Q3 		$44K Sell
5,400
-66,400
-92% -$456K ﹤0.01% 5502
2022
Q2 		$406K Buy
71,800
+31,100
+76% +$180K ﹤0.01% 3624
2022
Q1 		$228K Buy
40,700
+40,200
+8,040% +$203K ﹤0.01% 4658
2021
Q4 		$2K Hold
500
– – ﹤0.01% 7869
2021
Q3 		$5K Sell
500
-200
-29% -$1.5K ﹤0.01% 7729
2021
Q2 		$5K Sell
700
-17,300
-96% -$115K ﹤0.01% 7756
2021
Q1 		$1.12M Buy
18,000
+17,700
+5,900% +$133K ﹤0.01% 3098
2020
Q4 		$2K Sell
300
-5,400
-95% -$41.1K ﹤0.01% 6240
2020
Q3 		$35K Buy
5,700
+600
+12% +$4.23K ﹤0.01% 4855
2020
Q2 		$43K Buy
+5,100
New +$37.9K ﹤0.01% 4455

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Group One Trading's FENC Position: Q4 2022 in Review

Group One Trading sold out of Fennec Pharmaceuticals (FENC) in Q4 2022, closing a stake of 14,924 shares — an estimated $132K sold.

Group One Trading first reported a position in FENC in Q4 2020 and held it in 3 quarters. The position peaked at $121K in Q3 2022. 43 funds tracked by Wall St. Rank hold FENC as of Q4 2022.

  • Group One Trading reported no remaining Fennec Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 14,924 Fennec Pharmaceuticals shares in Q4 2022, an estimated $132K.
  • Group One Trading first reported a position in Fennec Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Group One Trading's Fennec Pharmaceuticals position peaked at $121K in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.